Learning CenterEducational ActivitiesView
Meeting

Pediatric Rheumatology Symposium

Date:

To Be Announced

Location:

To Be Announced

Program Information

This unique symposium will provide the most up-to-date, practical clinical information and basic science knowledge on the diagnosis and management of pediatric patients with rheumatic diseases and immune disorders.

See information from the 2021 meeting below.

Syllabi

Program syllabi will be available online during the meeting and for 12 months after the meeting to registered attendees only. To access syllabi, login and go to My Educational Activities.

CME and MOC Information

Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The ACR designates this enduring activity for a maximum of (to be announced) AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to (to be announced) MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

ABP MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to (to be announced) MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

By completing this activity you provide the ACR permission to share completion data with the ACCME and the certifying board(s).

ABIM MOC Badge

Faculty and Disclosures

ACR Disclosure Statement

It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

Nature of Financial Relationships

Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience all financial relationships with ineligible companies any financial or other relationship(s) with a ineligible company including, but not limited to:

  1. Advisor or Review Panel member
  2. Consultant
  3. Employee
  4. Officer or Board Member
  5. Grant/Research Support
  6. Speaker/Honoraria includes speakers bureau, symposia, and expert witness
  7. Independent Contractor
  8. Ownership Interest
  9. Royalties
  10. Intellectual Property/Patents
  11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan
  12. Other Financial or Material Support

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

See 2021 disclosures in the 2021 meeting section below.

Corporate Support

The American College of Rheumatology thanks our corporate supporters and partners for their commitment to advancing rheumatology by supporting ACR and ARP programs and initiatives. See current supporters, guidelines, and benefits of supporting the ACR.

2021 Pediatric Rheumatology Symposium

See information from the 2021 Pediatric Rheumatology Symposium.

CME: 31.75    MOC: 31.37

The deadline to claim 2021 credit was September 16, 2021 at 11:59 PM ET.

Target Audience
Rheumatologists, physicians and other healthcare providers who care for pediatric patients with rheumatic diseases, clinical investigators, physician-scientists and those interested or engaged in research in the field of pediatric rheumatic diseases.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Discuss the most up-to-date clinical information on the diagnosis and management of pediatric patients with rheumatic and immunologic disorders
  • Describe the most current information regarding the pathophysiology underlying pediatric rheumatic disorders

Disclosures
View 2021 Pediatric Rheumatology Symposium Disclosures

Abstracts
We have made the difficult decision not to accept abstracts for the 2021 meeting. The innovation and collaboration typically showcased in the abstracts program are unparalleled and will be missed. We hope to bring abstracts back to PRSYM in the future.

View 2020 abstracts

2020 Pediatric Rheumatology Symposium Slide Decks

The Pediatric Rheumatology Symposium (PRSYM) Spotlight Slide Decks feature key highlights from some of the most notable abstracts in select categories accepted for the PRSYM 2020 Symposium. Summarized by the authors, these slides can be used to reinforce learning and/or as a teaching resource to share content with others.

Clinical and Therapeutic Aspects  

Genetics and Pathogenesis  

Quality, Health, and Education Research  

Quick Links

Contact Info / Inquiries

American College of Rheumatology
education@rheumatology.org
404-633-3777

© 2022 American College of Rheumatology.  All rights reserved.  Website & Privacy Policies | Sitemap | Help | Contact Us